Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 8, 2013Journal of Leukocyte BiologyOpen Access

TLR agonists: our best frenemy in cancer immunotherapy

View Full Paper
Ask AI
Bookmark
Share

Authors

SKSabina KaczanowskaNational Institutes of HealthAJAnn Mary JosephImmunai (United States)EDEduardo DávilaNew Mexico State University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kaczanowska et al. (2013) studied this question.

synapsesocial.com/papers/6a70ee98660549caf2c592bbhttps://doi.org/10.1189/jlb.1012501
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The role of interleukin-8 in cancer cells and microenvironment interaction2005 · 253 citations
  2. 2Tolerance, Danger, and the Extended Family1994 · 4,835 citations
  3. 3Mal Mediates TLR-Induced Activation of CREB and Expression of IL-102011 · 91 citations
  4. 4Tumour suppression induced by the macrophage activating lipopeptide MALP-2 in an ultrasound guided pancreatic carcinoma mouse model2004 · 63 citations